Anders Wieslander

3.0k total citations
69 papers, 2.4k citations indexed

About

Anders Wieslander is a scholar working on Nephrology, Clinical Biochemistry and Surgery. According to data from OpenAlex, Anders Wieslander has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Nephrology, 20 papers in Clinical Biochemistry and 13 papers in Surgery. Recurrent topics in Anders Wieslander's work include Dialysis and Renal Disease Management (48 papers), Advanced Glycation End Products research (20 papers) and Muscle and Compartmental Disorders (11 papers). Anders Wieslander is often cited by papers focused on Dialysis and Renal Disease Management (48 papers), Advanced Glycation End Products research (20 papers) and Muscle and Compartmental Disorders (11 papers). Anders Wieslander collaborates with scholars based in Sweden, Germany and United States. Anders Wieslander's co-authors include Per Kjellstrand, Torbjörn Lindén, Bengt Rippe, Reinhold Deppisch, Ola Carlsson, Ulf Boberg, Ole Simonsen, Thomas Henle, Eva Svensson and Gabriela Godaly and has published in prestigious journals such as PLoS ONE, Kidney International and Intensive Care Medicine.

In The Last Decade

Anders Wieslander

67 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Wieslander Sweden 28 1.8k 699 585 385 344 69 2.4k
Marion Moréna France 29 1.5k 0.8× 688 1.0× 165 0.3× 221 0.6× 432 1.3× 97 2.6k
Miriam F. Weiss United States 15 455 0.2× 161 0.2× 704 1.2× 140 0.4× 146 0.4× 21 1.4k
F. Scheler Germany 20 705 0.4× 465 0.7× 98 0.2× 281 0.7× 136 0.4× 173 1.9k
Raymond Vanholder Belgium 11 702 0.4× 304 0.4× 98 0.2× 134 0.3× 123 0.4× 14 1.3k
Katarzyna Korybalska Poland 19 530 0.3× 343 0.5× 111 0.2× 155 0.4× 90 0.3× 71 1.4k
Andréa Emília Marques Stinghen Brazil 23 758 0.4× 184 0.3× 144 0.2× 129 0.3× 41 0.1× 61 1.6k
Helmut Graf Austria 24 662 0.4× 305 0.4× 63 0.1× 197 0.5× 48 0.1× 54 1.9k
Tammy L. Sirich United States 20 1.1k 0.6× 248 0.4× 90 0.2× 109 0.3× 117 0.3× 41 1.9k
Fuyuhiko Nishijima Japan 32 1.2k 0.6× 233 0.3× 202 0.3× 192 0.5× 19 0.1× 37 2.4k
Tatsuo Yamamoto Japan 24 677 0.4× 329 0.5× 61 0.1× 268 0.7× 26 0.1× 82 2.4k

Countries citing papers authored by Anders Wieslander

Since Specialization
Citations

This map shows the geographic impact of Anders Wieslander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Wieslander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Wieslander more than expected).

Fields of papers citing papers by Anders Wieslander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Wieslander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Wieslander. The network helps show where Anders Wieslander may publish in the future.

Co-authorship network of co-authors of Anders Wieslander

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Wieslander. A scholar is included among the top collaborators of Anders Wieslander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Wieslander. Anders Wieslander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bodelsson, Mikael, et al.. (2022). Analysis of acid–base disorders in an ICU cohort using a computer script. Intensive Care Medicine Experimental. 10(1). 11–11. 5 indexed citations
2.
Nilsson, Anders, et al.. (2021). Mathematical modelling of post-filter ionized calcium during citrate anticoagulated continuous renal replacement therapy. PLoS ONE. 16(2). e0247477–e0247477. 1 indexed citations
3.
Broman, Marcus, Bengt Klarin, Ola Carlsson, et al.. (2015). Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement. ASAIO Journal. 61(4). 437–442. 5 indexed citations
4.
Broman, Marcus, Ola Carlsson, Hans Friberg, Anders Wieslander, & Gabriela Godaly. (2010). Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiologica Scandinavica. 55(1). 39–45. 63 indexed citations
5.
Bender, Thorsten O., Klaus Kratochwill, Janusz Witowski, et al.. (2010). Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells. Nephrology Dialysis Transplantation. 26(3). 1046–1052. 15 indexed citations
6.
Kihm, Lars, M.-L. Gross, Reinhold Deppisch, et al.. (2008). Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure. European Journal of Clinical Investigation. 38(5). 296–305. 32 indexed citations
7.
Bręborowicz, Andrzej, Krzysztof Pawlaczyk, Alicja Połubińska, et al.. (2006). Effect of peritoneal dialysis on renal morphology and function. Nephrology Dialysis Transplantation. 21(12). 3539–3544. 12 indexed citations
8.
Leung, Joseph C.K., Loretta Y.Y. Chan, Sydney Tang, et al.. (2005). Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF. Nephrology Dialysis Transplantation. 20(7). 1336–1349. 46 indexed citations
9.
Lai, Kar Neng, Joseph C.K. Leung, Loretta Y.Y. Chan, et al.. (2004). Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products. Clinical & Experimental Immunology. 138(3). 466–475. 36 indexed citations
10.
Simonsen, Ole, Daniele Venturoli, Anders Wieslander, Ola Carlsson, & Bengt Rippe. (2003). Mass transfer of calcium across the peritoneum at three different peritoneal dialysis fluid Ca2+ and glucose concentrations. Kidney International. 64(1). 208–215. 15 indexed citations
11.
Rippe, Bengt, Anders Wieslander, & Barbara Musi. (2003). Long-Term Results with Low Glucose Degradation Product Content in Peritoneal Dialysis Fluids. Contributions to nephrology. 47–55. 7 indexed citations
12.
Lindén, Torbjörn, Arieh S. Cohen, Reinhold Deppisch, Per Kjellstrand, & Anders Wieslander. (2002). 3,4-Dideoxyglucosone-3-ene (3,4-DGE): A cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney International. 62(2). 697–703. 120 indexed citations
13.
Eriksson, C., et al.. (2001). Protection by glutathione of neutrophils against the toxic effects of peritoneal dialysis fluid. Toxicology in Vitro. 15(6). 655–661. 5 indexed citations
14.
Rippe, Bengt, Ole Simonsen, Olof Heimbürger, et al.. (2001). Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney International. 59(1). 348–357. 197 indexed citations
15.
Lindén, Torbjörn, et al.. (1998). 3-Deoxyglucosone, a Promoter of Advanced Glycation end Products in Fluids for Peritoneal Dialysis. Peritoneal Dialysis International. 18(3). 290–293. 98 indexed citations
16.
Musi, Barbara, Ola Carlsson, Anna Rippe, Anders Wieslander, & Bengt Rippe. (1998). Effects of Acidity, Glucose Degradation Products, and Dialysis Fluid Buffer Choice on Peritoneal Solute and Fluid Transport in Rats. Peritoneal Dialysis International. 18(3). 303–310. 39 indexed citations
17.
Wieslander, Anders, et al.. (1993). In Vitro Toxicity of Biomaterials Determined with Cell Density, Total Protein, Cell Cycle Distribution and Adenine Nucleotides. Biomaterials Artificial Cells and Immobilization Biotechnology. 21(1). 63–70. 6 indexed citations
18.
Wieslander, Anders, et al.. (1992). Toxicity of Heat Sterilized Peritoneal Dialysis Fluids is Derived from Degradation of Glucose. ASAIO Journal. 38(3). M370–M372. 44 indexed citations
19.
Wieslander, Anders, et al.. (1991). Effects of exposure period of acetylsalicylic acid, paracetamol and isopropanol on L929 cytotoxicity. Toxicology in Vitro. 5(5-6). 449–450. 8 indexed citations
20.
Wieslander, Anders, Å. Magnusson, & Per Kjellstrand. (1990). Use of Cell Culture to Predict Toxicity of Solid Materials in Blood Contact. Biomaterials Artificial Cells and Artificial Organs. 18(3). 367–374. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marion Moréna Breakdown of academic impact, for papers by Miriam F. Weiss Breakdown of academic impact, for papers by F. Scheler Breakdown of academic impact, for papers by Raymond Vanholder Breakdown of academic impact, for papers by Katarzyna Korybalska Breakdown of academic impact, for papers by Andréa Emília Marques Stinghen Breakdown of academic impact, for papers by Helmut Graf Breakdown of academic impact, for papers by Tammy L. Sirich Breakdown of academic impact, for papers by Fuyuhiko Nishijima Breakdown of academic impact, for papers by Tatsuo Yamamoto
Rankless by CCL
2026